Merck bags EU nod for infant RSV protection in major public health milestone
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Move strengthens footprint in Western India and expands multi-specialty care network
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
The investment case for health technology in India is frequently overstated in one direction and understated in another
Revvity is positioning its technologies as a connected engine for discovery
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
Subscribe To Our Newsletter & Stay Updated